Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Invested Capital (2024 - 2025)

Historic Invested Capital for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $164.1 million.

  • Kestra Medical Technologies' Invested Capital rose 16936.57% to $164.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $164.1 million, marking a year-over-year increase of 16936.57%. This contributed to the annual value of $246.5 million for FY2025, which is 24774.79% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Invested Capital stood at $164.1 million for Q4 2025, which was up 16936.57% from $225.6 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Invested Capital high stood at $246.5 million for Q2 2025, and its period low was -$424.4 million during Q1 2025.